default author photo

Fumihito Hirai

Fukuoka University Chikushi Hospital - Department of Gastroenterology

Fukuoka 814-0180

Japan

SCHOLARLY PAPERS

2

DOWNLOADS

192

TOTAL CITATIONS

12

Scholarly Papers (2)

1.

AJM300 (Carotegrast Methyl), an Oral Antagonist of α4-Integrin, as Induction Therapy for Patients with Moderately Active Ulcerative Colitis: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase 3 Study

Number of pages: 24 Posted: 06 Dec 2021
Toho University Sakura Medical Center - Department of Internal Medicine, Tokyo Medical and Dental University - Department of Gastroenterology and Hepatology, Ohmori Toshihide gastro-intestinal Clinic - Gastroenterology, Matsushima Clinic Yokohama Japan - Department of gastrointestinal division, Ishida Clinic of IBD and Gastroenterology - IBD and Gastroenterology, National Hospital Organization Hirosaki National Hospital - Department of Gastroenterology and Hematology, Kanke Gastrointestinal Clinic - Gastrointestinal division, Kitasato University - Research and Development Center for New Medical Frontiers, Fukuoka University Chikushi Hospital - Department of Gastroenterology, Hyogo College of Medicine - Center for Inflammatory Bowel Disease, Division of Internal Medicine, National Center of Neurology and Psychiatry, National Center of Neurology and Psychiatry (NCNP) Hospital - Department of Neurology, Komagome Hospital - Department of Neurology, EA Pharma Co., Ltd. - Clinical Development Department, EA Pharma Co., Ltd. - Clinical Development Department, Kitasato University - Center for Advanced IBD Research and Treatment and Toho University Sakura Medical Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine
Downloads 121 (592,433)
Citation 10

Abstract:

Loading...

alpha 4-integrin antagonist, carotegrast methyl, Mayo Clinic scores, induction therapy, randomised controlled study, Ulcerative colitis

2.

Discontinuation of Infliximab Increases the 1-Year Relapse Rate of Ulcerative Colitis in Remission - A Prospective, Multicentre, Randomised Controlled Trial

Number of pages: 33 Posted: 14 Jan 2021
Kitasato University - Center for Advanced IBD Research and Treatment, Sapporo Kosei General Hospital - IBD Center, Hyogo College of Medicine - Department of Inflammatory Bowel Disease, Yokkaichi Hazu Medical Center - IBD Center, Tokyo Medical and Dental University - Department of Gastroenterology and Hepatology, Hiroshima University Hospital - Department of Endoscopy and Medicine, Kyorin University School of Medicine - Department of Gastroenterology and Hepatology, Fukuoka University Chikushi Hospital - Department of Gastroenterology, Sapporo Medical University - Department of Gastroenterology, Hyogo College of Medicine - Center for Inflammatory Bowel Disease, Iwate Medical University - Division of Gastroenterology, Hirosaki Municipal Hospital - Department of Pathology, Yokohama City University - Department of Data Science, Toho University Sakura Medical Center, Tokyo Medical and Dental University - Department of Gastroenterology and Hepatology, Kitasato University - Center for Advanced IBD Research and Treatment and Independent
Downloads 71 (867,774)
Citation 2

Abstract:

Loading...